Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Equity: $46,549M in FY2025, up 5.5% from a year earlier.
Latest, FY2025
46,549
Period ended Dec 31, 2025
Change on a year earlier
+5.5%
44,126 in FY2024
History
12 years
Since FY2014
Sources
9
Documents cited below
Where the FY2025 figure comes from
Source: Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Reported in Postgres DB + Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Novartis Total Equity ($M), annual FY2014–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-equity-total
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.